Skip to main content

Abstract

Background and Purpose—

First pass (FP) recanalization has been shown to be a predictor of favorable outcome in endovascular treatment of stroke. The reasons why FP recanalization leads to better outcome as compared with multiple passes (MP) are unknown. We aim to investigate the recanalization pattern and its relationship with outcome.

Methods—

Six hundred nine consecutive patients underwent endovascular treatment. Recanalization was defined as modified Thrombolysis in Cerebral Infarction score 2B-3. Favorable outcome was defined as modified Rankin Scale score of 0 to 2 at 90 days. Sudden recanalization (SR) was considered when modified Thrombolysis in Cerebral Infarction score varied from 0-1 to 2B-3 in a single pass. Progressive recanalization (PR) was considered if modified Thrombolysis in Cerebral Infarction score 2A was achieved at an interim pass before achieving recanalization. Patients were also categorized as recanalizers at FP, MP, or nonrecanalizers.

Results—

Five hundred nine (83.9%) patients achieved recanalization. SR was achieved in 378 (62.1%) patients; 280 (46%) were FP-SR, and 98 (16.1%) were MP-SR. MP-PR was achieved in 131 (21.5%) patients. Rates of favorable outcome were similar between patients with FP-SR (57.5%) and MP-SR (57.1%; odds ratio [OR], 0.9 [CI, 0.53–1.54]; P=0.7) but lower in MP-PR (29.8%; OR, 3.33 [CI, 1.71–5.63]; P<0.01). Patients with MP-PR had better outcome than nonrecanalizer (17%; OR, 2.93 [CI, 1.42–6.15]; P<0.01). In univariate analysis, both FP recanalization (OR, 1.91 [CI, 1.31–2.72]; P<0.01) and SR (OR, 3.19 [CI, 2.12–4.95]; P<0.01) were associated with favorable outcome. However multivariate analysis adjusting for FP recanalization showed that the only procedural predictor of favorable outcome was SR (OR, 3.12 [CI, 1.91–5.16]; P<0.01). Higher number of passes were associated with worse outcome in patients with recanalization (OR, 0.75 [CI, 0.66–0.85]; P<0.01) but not in those with SR (OR, 0.94 [CI, 0.59–1.61]; P=0.937).

Conclusions—

SR strongly predicts favorable outcome in patients undergoing endovascular treatment, even after previous unsuccessful attempts. PR may reflect clot fragmentation and embolization due to more friable composition, leading to worse outcomes. Prospective studies with independent assessment of recanalization pattern should validate these results.
The influence of the number of device passes on outcome in patients with acute ischemic stroke secondary to large vessel occlusion treated with endovascular therapy (EVT) has been an important issue in different studies published lately.1,2 The mechanisms by which a higher number of passes negatively influence outcome are uncertain.
Since the initial description of first pass effect,3 different studies have characterized the detrimental effect of accumulated device passes: each additional pass negatively impacts final outcome despite recanalization.1 Moreover, the rate of hemorrhagic transformation has been associated with higher number of passes.4 We hypothesized that clot fragmentation and circumstances leading to whole clot retrieval in one single pass (sudden recanalization [SR]), even after unsuccessful attempts, may be associated with better outcome. On the contrary, cases in which the same degree of recanalization was progressively achieved in several passes, reflecting a clot composition or techniques favoring fragmentation, may have a worse prognosis.

Methods

The data that support the findings of this study are available on reasonable request. Ethics approval was obtained from the local institutional review board, and written informed consent was obtained from patients.

Patient Selection

We performed a retrospective analysis that includes all patients undergoing EVT at our comprehensive stroke center since 2014. Patients were selected if they had an acute ischemic stroke secondary to an occlusion of terminal intracranial carotid artery or M1-M2 middle cerebral artery, an Alberta Stroke Program Early CT Score of ≥5, and were treated with EVT(n=679).

Clinical and Imaging Assessment

Clinical, imaging, and procedural data were prospectively collected. Intravenous tPA (tissue-type plasminogen activator) was administered according to center guidelines. Favorable outcome was defined as a modified Rankin Scale score of ≤2 at 90 days assessed by a blinded observer. Hemorrhagic transformation was assessed in a computed tomographic scan performed 48 to 72 hours following ECASS-II (European Cooperative Acute Stroke Study) criteria.
Degree of recanalization after each device pass was prospectively determined using modified Thrombolysis in Cerebral Infarction (mTICI) grading standards consensus. Patients with final mTICI2C were included in the mTICI3 group. Recanalization was considered when mTICI2B-3 degree was achieved.5
SR was considered when mTICI score varied from 0-1 to 2B-3 in a single pass. Progressive recanalization (PR) was considered if mTICI2A was achieved at an interim pass before achieving recanalization (mTICI2B-3). Patients were also categorized as recanalizers at first pass and multiple passes (MP) or nonrecanalizers.
Seventy patients (10.3%) in the MP group were excluded from the final analysis because of missing data regarding recanalization status at interim passes. Table I in the Data Supplement shows demographic, clinical, procedural, and outcomes variables of excluded patients, Table II in the Data Supplement shows demographics of the study population, and Figure I in the Data Supplement shows a flowchart detailing recanalization pattern for each device pass attempted.

Statistical Analysis

Univariate comparisons were performed by Fisher exact test, Pearson χ2, Spearman correlation test, or Mann-Whitney U test, as appropriate to the type of variable and its distribution. Continuous variables are displayed as median and interquartile range. Categorical variables are displayed by number and frequencies. Multivariate regression models were performed to evaluate association of different variables with favorable outcome and SR. All analyses were performed using SPSS Statistics, version 25 (IBM, Armonk).

Results

A total of 609 patients were included in the study. Median National Institutes of Health Stroke Scale score was 17 (interquartile range, 11–20) and Alberta Stroke Program Early CT Score 9 (interquartile range, 8–10). Five hundred and nine patients (83.9%) achieved recanalization. At 3 months, 273 patients (44.8%) were functionally independent and 131 patients had died (21.5%).
The Table shows baseline characteristics, rates, and outcomes according to recanalization pattern. Figure 1 shows stacked bars with functional outcome depending on recanalization pattern.
Table. Clinical, Imaging, Procedural and Outcomes of Patients Depending on Recanalization Pattern
 SRNo SRSR vs No SRMP-SR vs MP-PR
FP-SRMP-SRMP-PRNR
n=280 (46%)n=98 (16.1%)n=131 (21.5%)n=100 (16.4%)OR (95% CI)OR (95% CI)
Clinical and imaging features
 NIHSS, median (IQR)16 (11–20)17 (13–20)18 (15–21)17 (10–19)0.98 (0.93–1.02)0.99 (0.93–1.05)
 Side (right), n (%)135 (48.2)44 (44.9)57 (43.5)39 (39)1.07 (0.70–1.65)1.61 (0.85–3.06)
 ASPECTS, median (IQR)9 (8–10)9 (8–10)9 (8–10)9 (8–10)1.04 (0.88–1.23)0.94 (0.74–1.20)
 Occlusion site, n (%)
  TICA44 (15.7)28 (28.6)42 (32.1)20 (20)1.47 (1.05–2.06)*0.83 (0.43–1.60)
  M1-MCA153 (54.6)56 (57.1)71 (54.2)51 (51)
  M2-MCA83 (29.7)14 (14.3)18 (13.7)29 (29)
 Tandem occlusion, n (%)59 (21.1)22 (22.4)27 (20.6)26 (26)0.92 (0.75–1.21)0.75 (0.36–1.58)
 tPA, n (%)128 (45.7)50 (51)50 (38.2)5 (50)1.00 (0.65–1.55)0.81 (0.43–1.53)
Procedural features
 Stent retriever, n (%)252 (90)88 (89.8)120 (91.6)93 (93)0.96 (0.47–1.97)0.80 (0.29–2.22)
 Balloon-guided catheter, n (%)46 (16.4)23 (23.5)24 (18.3)15 (15)1.22 (0.71–2.09)0.87 (0.42–1.85)
 Distal aspiration, n (%)172 (61.4)70 (71.4)91 (69.5)58 (58)0.95 (0.61–1.46)0.83 (0.43–1.60)
 Final mTICI3, n (%)185 (66.1)50 (51)43 (32.8)0 (0)5.83 (3.70–9.09)*2.13 (1.24–3.65)*
 TOR, min; median (IQR)266 (185–434)280 (188–420)325 (210–539) 0.99 (0.97–0.99)*0.99 (0.99–1.01)
 Perforation/vasospasm, n (%)9 (3.2)5 (5.1)5 (3.9)13 (13)0.45 (0.22–0.93)*0.48 (0.10–2.15)
Outcomes
 mRS ≤2 at 90 d, n (%)161 (57.5)56 (57.1)39 (29.8)17 (17)3.33 (2.12–5.23)*3.12 (1.89–5.12)*
 HT, n (%)38 (13.6)25 (25.5)24 (18.3)35 (35)0.59 (0.39–0.87)*1.53 (0.81–2.88)
 sICH, n (%)13 (4.6)5 (5.1)10 (7.6)18 (18)0.36 (0.19–0.67)*0.65 (0.22–1.97)
 Mortality, n (%)41 (14.6)12 (12.2)41 (31.3)37 (37)0.32 (0.22–0.47)*0.31 (0.15–0.62)*
ASPECTS indicates Alberta Stroke Program Early CT Score; FP, first pass; HT, hemorrhagic transformation; IQR, interquartile range; MCA, middle cerebral artery; MP, multiple passes; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institutes of Health Stroke Scale; NR, nonrecanalizer; OR, odds ratio; PR, progressive recanalization; sICH, symptomatic hemorrhagic transformation; SR, sudden recanalization; TICA, terminal internal carotid artery; TOR, time onset-recanalization; and tPA, tissue-type plasminogen activator.
*
Statistically significant variables for a P value <0.05.
Figure 1. Grotta bars detailing functional outcome of patients. A, Functional outcome depending on recanalization pattern. B, Functional outcome depending on the number of device passes in patients with sudden recanalization. FP indicates first pass; MP, multiple passes; mRS, modified Rankin Scale; NR, nonrecanalizer; PR, progressive recanalization; and SR, sudden recanalization.
Among SR patients, the number of passes was not associated with functional outcome (odds ratio [OR], 0.94 [CI, 0.59–1.61]; P=0.937; Figure 1). There was a progressive decline in SR rate for each device pass attempted (OR, 0.43 [CI, 0.37–0.491]; P<0.01; Figure 2). The only variable associated with a higher proportion of SR was the presence of a more distal occlusion (terminal intracranial carotid artery, 54%, versus M1-middle cerebral artery, 63%, versus M2-middle cerebral artery, 67%; OR, 0.64 [CI, 0.44–0.95]; P=0.02; Table).
Figure 2. Rate of sudden recanalization depending on the number of passes attempted.
Multivariate analysis adjusted by confounding factors (Table III in the Data Supplement), including first pass recanalization, showed that SR was the strongest predictor of good functional outcome in patients with recanalization (OR, 3.1 [CI, 1.9–5.1]; P<0.01) and a predictor of absence of symptomatic and nonsymptomatic hemorrhage (OR, 0.4 [CI, 0.2–0.7]; P=0.002 and OR, 0.6 [CI, 0.4–0.9]; P=0.016, respectively).
Among patients with recanalization after MP (n=229; 37%), multivariate analysis showed that PR pattern, as compared with SR, had a negative impact in rate of good functional outcome (30% versus 57%, respectively; OR, 0.3 [CI, 0.2–0.6]; P<0.01) and worse final recanalization degree (final mTICI3: MP-PR, 33%, versus MP-SR, 51%; OR, 2.1 [CI, 1.2–3.6]; P<0.01). However, patients with MP-PR had significantly better functional outcome than patients with nonrecanalizer (30% versus 17%; OR, 2.9 [CI, 1.4–6.1]; P<0.01).

Discussion

Our study shows that patients who underwent EVT because of a large vessel occlusion stroke of the anterior circulation who achieved an SR pattern had better functional outcome. Patients who experienced an SR had similar rate of disability if recanalization was achieved in a single pass or in MP (Figure 1). On the other hand, the clinical benefits associated with recanalization were blunted if recanalization was progressively achieved in several passes. Finally, the inability to achieve recanalization was always associated to worse outcome, supporting the concept that recanalization should be the ultimate goal of EVT.2
Several mechanisms have been proposed to explain the negative impact of additional device passes in patients with stroke undergoing EVT. Repeated device/clot interactions may lead to changes in clot morphology and composition that increases its friction coefficient making retrieval progressively more difficult.6 Thrombus composition per-pass analysis shows a higher fibrin percentage in thrombus fragments after second device pass,7 expressing a dynamic evolution with each device pass. In addition, the device footprint on the vessel wall considered harmless in a single pass may induce a clinically relevant accumulated damage when successive passes are attempted.
We hypothesized that clot composition and its fragmentability may also explain at least to some extent the benefits of the first pass recanalization observed in previous studies.1,3 Theoretically friable clots might be more prone to fragmentation during the retrieval maneuvers, embolizing particles of different size.8 On the other hand, firm, solid clots may require several unsuccessful passes (unchanged mTICI) until a definitive attempt is able to retrieve the whole clot supporting our definition of SR.
The fragmentability of the clot may be due to its composition but also to the devices, combinations, and procedural techniques used. The present work is a hypothesis-generating study and did not address several relevant issues. Future studies should focus on the relationship between the device used and SR, to determine potential differences between them. Also, histological studies should determine whether SR is associated with a particular clot composition.
Our study has 2 major limitations. It is a single-center retrospective study, and recanalization degree was not assessed by a blinded core imaging laboratory. In 70 patients, detailed information about per-pass recanalization was missing and was excluded from the study.

Conclusions

SR is a strong predictor of good functional outcome in patients undergoing EVT, even if previous recanalization attempts failed. PR may reflect clot fragmentation and embolization due to more friable composition, leading to worse outcomes. Prospective studies with independent assessment of recanalization pattern should validate these results.

Supplemental Material

File (str_stroke-2019-028787d_supp1.pdf)

References

1.
Garcia-Tornel A, Requena M, Rubiera M, Muchada M, Pagola J, Rodriguez-Luna D, et al. When to stop. Stroke. 2019;50:1781–1788. doi: 10.1161/STROKEAHA.119.025088
2.
Jindal G, Carvalho HP, Wessell A, Le E, Naragum V, Miller TR, et al. Beyond the first pass: revascularization remains critical in stroke thrombectomy. J Neurointerv Surg. 2019;11:1095–1099. doi: 10.1136/neurintsurg-2019-014773
3.
Zaidat OO, Castonguay AC, Linfante I, Gupta R, Martin CO, Holloway WE, et al. First pass effect: a new measure for stroke thrombectomy devices. Stroke. 2018;49:660–666. doi: 10.1161/STROKEAHA.117.020315
4.
Bourcier R, Saleme S, Labreuche J, Mazighi M, Fahed R, Blanc R, et al; ASTER Trial Investigators. More than three passes of stent retriever is an independent predictor of parenchymal hematoma in acute ischemic stroke. J Neurointerv Surg. 2019;11:625–629. doi: 10.1136/neurintsurg-2018-014380
5.
Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al; Cerebral Angiographic Revascularization Grading (CARG) Collaborators; STIR Revascularization Working Group; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44:2650–2663. doi: 10.1161/STROKEAHA.113.001972
6.
Flottmann F, Leischner H, Broocks G, Nawabi J, Bernhardt M, Faizy TD, et al. Recanalization rate per retrieval attempt in mechanical thrombectomy for acute ischemic stroke. Stroke. 2018;49:2523–2525. doi: 10.1161/STROKEAHA.118.022737
7.
Duffy S, McCarthy R, Farrell M, Thomas S, Brennan P, Power S, et al. Per-pass analysis of thrombus composition in patients with acute ischemic stroke undergoing mechanical thrombectomy. Stroke. 2019;50:1156–1163. doi: 10.1161/STROKEAHA.118.023419
8.
Caroff J, King RM, Arslanian R, Marosfoi M, Langan ET, Gounis MJ, et al. Microcatheter navigation through the clot: does size matter? J Neurointerv Surg. 2019;11:271–274. doi: 10.1136/neurintsurg-2018-014105

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Stroke
Go to Stroke
Stroke
Pages: 1313 - 1316
PubMed: 32078495

Versions

You are viewing the most recent version of this article.

History

Received: 20 September 2019
Revision received: 13 January 2020
Accepted: 17 January 2020
Published online: 14 February 2020
Published in print: April 2020

Permissions

Request permissions for this article.

Keywords

  1. humans
  2. prognosis
  3. prospective studies
  4. stroke
  5. thrombectomy

Subjects

Authors

Affiliations

Álvaro García-Tornel, MD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Marta Rubiera, MD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Manuel Requena, MD, PhD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Marian Muchada, MD, PhD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Jorge Pagola, MD, PhD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
David Rodriguez-Luna, MD, PhD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Matias Deck, MD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Jesus Juega, MD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Noelia Rodríguez-Villatoro, MD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Sandra Boned, MD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Marta Olivé-Gadea, MD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
Alejandro Tomasello, MD
Department of Neurorradiology (A.T., C.P., D.H.), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.T., C.P., D.H.), Universitat Autònoma de Barcelona, Spain.
Carlos Piñana, MD
Department of Neurorradiology (A.T., C.P., D.H.), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.T., C.P., D.H.), Universitat Autònoma de Barcelona, Spain.
David Hernández, MD
Department of Neurorradiology (A.T., C.P., D.H.), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.T., C.P., D.H.), Universitat Autònoma de Barcelona, Spain.
Carlos A. Molina, MD, PhD
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.
From the Stroke Unit, Department of Neurology (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Hospital Vall d’Hebron, Barcelona, Spain
Departament de Medicina (A.G.-T., M. Rubiera, M. Requena, M.M., J.P., D.R.-L., M.D., J.J., N.R.-V., S.B., M.O.-G., C.A.M., M. Ribo), Universitat Autònoma de Barcelona, Spain.

Notes

The Data Supplement is available with this article at Supplemental Material.
Correspondence to Marc Ribo, MD, PhD, Unitat d’Ictus, Hospital Vall d´Hebron, Passeig Vall d´Hebron 119-129, Barcelona 08035, Spain. Email [email protected]

Disclosures

Dr Ribo is a cofounder and shareholder of Anaconda-Biomed and has served as an advisor for Stryker, Medtronic, Vesalio, Anaconda Biomed, and Apta Targets. The other authors report no conflicts.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Water content for clot composition prediction in acute ischemic stroke, PLOS ONE, 19, 5, (e0304520), (2024).https://doi.org/10.1371/journal.pone.0304520
    Crossref
  2. Predicting Recanalization Failure With Conventional Devices During Endovascular Treatment Related to Vessel Occlusion, Stroke: Vascular and Interventional Neurology, 4, 5, (2024)./doi/10.1161/SVIN.124.001371
    Abstract
  3. Intracranial thrombus composition is associated with occlusion location and endovascular treatment outcomes: results from ITACAT multicenter study, Journal of NeuroInterventional Surgery, (jnis-2024-021654), (2024).https://doi.org/10.1136/jnis-2024-021654
    Crossref
  4. A prospective, multicentre, registry study of RECO in the endovascular treatment of acute ischaemic stroke, Scientific Reports, 14, 1, (2024).https://doi.org/10.1038/s41598-024-52207-z
    Crossref
  5. After early m TICI 2b, stop or continue? Insights from the PERSIST Registry , Annals of Clinical and Translational Neurology, 11, 7, (1921-1929), (2024).https://doi.org/10.1002/acn3.52115
    Crossref
  6. Complete Sudden Recanalization: There Is Hope Beyond the First Pass Effect, Stroke: Vascular and Interventional Neurology, 3, 2, (2023)./doi/10.1161/SVIN.122.000652
    Abstract
  7. Predictors of tissue infarction from distal emboli after mechanical thrombectomy, Journal of NeuroInterventional Surgery, 16, 10, (959-965), (2023).https://doi.org/10.1136/jnis-2023-020782
    Crossref
  8. Double stent-retriever as the first-line approach in mechanical thrombectomy: a randomized in vitro evaluation, Journal of NeuroInterventional Surgery, 15, 12, (1224-1228), (2023).https://doi.org/10.1136/jnis-2022-019887
    Crossref
  9. Granulocytes-Rich Thrombi in Cerebral Large Vessel Occlusion Are Associated with Increased Stiffness and Poorer Revascularization Outcomes, Neurotherapeutics, 20, 4, (1167-1176), (2023).https://doi.org/10.1007/s13311-023-01385-1
    Crossref
  10. Platelet Analysis in the Thrombus Plus Serum BNP for Detecting Clot-Related Atrial Fibrillation. Results From the ITACAT Multicentric Registry, Translational Stroke Research, (2023).https://doi.org/10.1007/s12975-023-01220-x
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

Sudden Recanalization
Stroke
  • Vol. 51
  • No. 4

Purchase access to this journal for 24 hours

Stroke
  • Vol. 51
  • No. 4
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Figures

Other

Tables

Share

Share

Share article link

Share

Comment Response